LifeStance Health (LFST) Operating Leases (2022 - 2026)

LifeStance Health has disclosed Operating Leases across 5 years of filings, most recently posting $148.8 million for Q1 2026.

• In Q1 2026, Operating Leases changed 0.38% year-over-year to $148.8 million; the TTM figure through Mar 2026 stood at $148.8 million (changed 0.38% YoY), while the FY2025 annual figure was $148.6 million, changed 0.1% from the prior year.
• Operating Leases was little changed at $148.8 million in Q1 2026, from $148.6 million in the prior quarter.
• Over the last five years, Operating Leases for LFST reached as high as $212.6 million in Q4 2022 and fell as low as $143.4 million in Q2 2025.
• The 5-year median for Operating Leases is $162.2 million (2024), against an average of $170.0 million.
• Annual changes were most pronounced in 2024 — Operating Leases decreased 19.38% — and 2025, when it dropped 0.1%.
• A 5-year view of Operating Leases shows it stood at $212.6 million in 2022, then dropped by 14.69% to $181.4 million in 2023, then retreated by 18.01% to $148.7 million in 2024, then decreased by 0.1% to $148.6 million in 2025, then advanced by 0.18% to $148.8 million in 2026.
• According to Business Quant data, Operating Leases over the past three periods registered $148.8 million, $148.6 million, and $144.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.